You have 1 adverse event management center in each vaccination training block: Center | India News

The center is looking forward to a “good decision” on the Covid-19 vaccine soon and has asked states to identify at least one adverse event management center in each block to monitor safety and effectiveness of the shots.
“When we undertake a universal immunization program, some side effects are seen in children and pregnant women after vaccination,” said Health Secretary Rajesh Bhushan. So, we cannot deny the chances of an adverse event when vaccination against Covid-19 begins. In countries where immunization has already begun, especially in the UK, adverse events have occurred on the very first day. So it is essential that states and UTs prepare for this as well, “he said.
Each vaccination session will be linked to a designated management center for adverse events after immunization (AEFI) to ensure that all of these events are effectively addressed and reported, officials said. The Ministry of Health has also issued guidelines for monitoring adverse events.
The process for authorizing the emergency use of Covid vaccines will not have an impact on vaccine release deadlines, as the government has already considered the scientific processes needed to ensure that approved vaccines are safe, aligned with global standards and effective. said Dr. VK Paul, NITI Aayog member and head of the national group of experts in vaccine administration.
“It simply came to our notice then. We look forward to a good decision soon, “said Paul.
Emphasizing that the vaccination action will involve a large number of beneficiaries in a short period of time and is different from regular immunization, the government stressed that monitoring adverse events in Covid-19 vaccine cases would also require additional efforts.
“This is a vaccine for adults, while our current AEFI is designed to monitor children and women. Second, these Covid vaccines are being developed on new platforms, even on multiple platforms, which makes it a complicated situation. We have to be very responsible. Vaccines are being reviewed on a scientific basis, and regulators will be looking for more than reasonable satisfaction to get approval, ”said Paul.
Bhushan said the states and territories of the Union must prepare for adverse events as part of the vaccination program.
The drug regulator is currently examining three applications from Pfizer, the Serum Institute of India (SII) and Bharat Biotech for authorization to use these vaccines urgently.
The government has also issued detailed guidelines to states to estimate requirements for the electric and non-electric cold chain. In all 29,000 points for the cold chain, 240 coolers, 70 freezers, 45,000 ice refrigerators, 41,000 freezers and 300 solar refrigerators are to be used, according to the health ministry.
The government also identified 23 ministries and departments at the central and state levels and assigned planning, implementation, social mobilization and awareness-raising roles for the vaccine launch.